Ocular surface disease has various causes, and in-office testing is one means to define those causes. Red eye: There is a test for that. Meibomian gland dysfunction: There is a test for that. Allergy: There is a test for that. Dry eye: There is a test for that — more than one.Point-of-care testing (POCT) is a growing area in ophthalmology in which clinicians obtain immediate results that enhance the accuracy of a diagnosis or help rule one out during one clinic visit. The most common testing done in an ophthalmologist’s (Read more...)
Rehab for age-related loss of vision cuts depression risk in half
Research finds that a technique called behavioral activation leads to a 50% decrease in the chances of people with age-related macular degeneration developing clinical depression.
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Status: Recruiting,
Condition Summary: Dry Eye Syndromes; Keratoconjunctivitis Sicca
Novel Eye Measure Finds Neuropathy in Prediabetes
Corneal confocal microscopy detected evidence of small-fiber neuropathy in patients who don’t even have diabetes yet but who have impaired glucose tolerance. Medscape Medical News
Integrated therapies can reduce depression by half among people with low vision due to AMD
The first clinical trial to examine integrated low vision and mental health treatment has shown that the approach can reduce the incidence of depression by half among people with low vision due to age-related macular degeneration (AMD).
Ab interno collagen stent offers minimally invasive aqueous drainage channel
A minimally invasive ab interno collagen stent may be a viable alternative to other glaucoma drainage methods, according to a review to be published in the Journal of Cataract & Refractive Surgery.In the review, author Richard A. Lewis, MD, explained that the XEN gel stent (Aquesys) — developed to avoid hypotony and optimize aqueous drainage to the subconjunctival space — has undergone extensive preclinical and animal testing, and clinical trials are now in progress.